Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: MetSense Pilot and Feasibility [NA]

View source ↗

Summary

MetSense pilot and feasibility trial is currently enrolling by invitation at Kaiser Permanente for serious mental illness and Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaiser Permanente | Conditions: Serious Mental Illness, Type 2 Diabetes | NA | Status: ENROLLING_BY_INVITATION